FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/02/031118 [Registered on: 09/02/2021] Trial Registered Prospectively
Last Modified On: 08/02/2021
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Prospective Analytical 
Study Design  Other 
Public Title of Study   CLINICAL, RADIOLOGICAL AND HISTOLOGICAL COMPARISON OF DEPTH OF INVASION IN ORAL CAVITY CANCER 
Scientific Title of Study   A CLINICOPATHOLOGICAL AND RADIOLOGICAL EVALUATION OF DEPTH OF INVASION IN CARCINOMA ORAL CAVITY 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Divyanshi Singh 
Designation  Junior Resident 
Affiliation  Indira Gandhi Medical College, Shimla 
Address  Department of Otorhinolaryngology, IGMC Shimla

Shimla
HIMACHAL PRADESH
171001
India 
Phone  9418725107  
Fax    
Email  divyanshi7singh@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr R S Minhas 
Designation  Professor 
Affiliation  Indira Gandhi Medical College, Shimla 
Address  Department of Otorhinolaryngology, IGMC Shimla

Shimla
HIMACHAL PRADESH
171001
India 
Phone  7018162141  
Fax    
Email  drraviminhas@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr R S Minhas 
Designation  Professor 
Affiliation  Indira Gandhi Medical College, Shimla 
Address  Department of Otorhinolaryngology, IGMC Shimla

Shimla
HIMACHAL PRADESH
171001
India 
Phone  7018162141  
Fax    
Email  drraviminhas@yahoo.com  
 
Source of Monetary or Material Support  
INDIRA GANDHI MEDICAL COLLEGE AND HOSPITAL, SHIMLA 
 
Primary Sponsor  
Name  Dr Divyanshi Singh 
Address  Department of Otorhinolaryngology, IGMC, Shimla 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Divyanshi Singh  IGMC, SHIMLA  Department of Otorhinolaryngology, IGMC, Shimla
Shimla
HIMACHAL PRADESH 
8219424706

divyanshi7singh@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE IGMC, SHIMLA  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C148||Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  1.00 Day(s)
Age To  99.00 Year(s)
Gender  Both 
Details  Patients with
1.Carcinoma buccal mucosa
2.Carcinoma anterior two-third part of tongue
3.Carcinoma floor of mouth
and who are eligible for wide local excision of the tumour.
 
 
ExclusionCriteria 
Details  Patients with
1.Carcinoma base of tongue
2.Carcinoma retromolar trigone area
3.Carcinoma posterior one-third part of tongue
4.Restricted mouth opening where ultrasound probe cannot be manipulated
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To find the feasibility of ultrasonography in assessing the depth of invasion in carcinoma oral cavity  The ultrasonographic assessment of depth of invasion will be done pre operatively which will be compared to depth of invasion on histopathological examination of the surgical specimen post-operatively. 
 
Secondary Outcome  
Outcome  TimePoints 
1.To find accuracy of ultrasonography in assessment of depth of invasion in the oral cavity carcinoma.
2.To find accuracy of clinical examination and Contrast Enhanced Computed Tomography in assessing depth of invasion in the oral cavity carcinoma.
3.To compare clinical examination, ultrasonography and Contrast Enhanced Computed Tomography findings in assessment of depth of invasion in oral cavity carcinoma.
 
The clinical, ultrasonographic and contrast enhanced computed tomography assessment of depth of invasion will be done pre operatively which will be compared to depth of invasion on histopathological examination of the surgical specimen post-operatively. 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   09/02/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   THE PATIENT WILL BE EXAMINED CLINICALLY AND DEPTH OF INVASION OF THE ORAL CAVITY CANCER WILL BE ASSESSED WHICH WILL BE FURTHER ASSESSED BY ULTRASONOGRAPHY, CONTRAST ENHANCED COMPUTED TOMOGRAPHY AND HISTOPATHOLOGICAL EXAMINATION OF THE SURGICAL RESECTED SPECIMEN. THE DEPTH OF INVASION ON HISTOPATHOLOGICAL EXAMINATION IS CONSIDERED THE GOLD STANDARD.
THE STUDY IS A PROSPECTIVE ANALYTICAL STUDY TO FIND THE FEASIBILITY OF ULTRASONOGRAPHY IN ASSESSMENT OF THE DEPTH OF INVASION IN CARCINOMA ORAL CAVITY.
 
Close